Miles Wang, an OpenAI researcher, is leaving to launch a $2B-valued startup focused on AI-driven drug discovery, with several colleagues expected to join the initiative.
Wang's new start-up will focus on AI-driven drug discovery
Jul 15, 2026
11:29 am
What's the storyMiles Wang, a prominent researcher at OpenAI, is leaving the company to start his own venture. His new start-up will focus on using artificial intelligence (AI) for drug discovery.
Several other researchers from OpenAI are also likely to join him in this new endeavor.
Miles Wang leaves OpenAI for a $2bn AI drug startup
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B | TechCrunch
Chai Discovery raises $400M for AI drug discovery as big pharma bets on machine learning over blockchain
Miles Wang, an OpenAI researcher, is in talks to raise $200M at a $2bn valuation for an AI drug-discovery startup that has no…
Lightspeed is in discussions to lead the funding round, sources say.
Four top Google AI minds, including Jeff Dean, are leaving to launch Discovery Loop, a groundbreaking startup focused on…
Chief scientist Jeff Dean is leaving Google to start a new company called Discovery Loop that wants to accelerate research using…
A prominent Google researcher is leaving for OpenAI, continuing a talent migration trend that has seen over 20 researchers depart…
Former employees at AI giants are raising hundreds of millions of dollars from investors months on from launching.
